cdr

Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Top

Chair(s)

  • Prof. Thomas Litman

    Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.

Speaker(s)

  • Prof. Thomas Litman

    Faculty of Health and Medical Sciences, Department of Immunology & Microbiology, University of Copenhagen, Copenhagen, Denmark.

    Topic: The ABC of MDR

  • Dr. Michael M. Gottesman

    Deputy Director for Intramural Research at the National Institutes of Health and Chief of the Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute. 

    Topic: Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier

  • Dr. Till Luckenbach

    Senior researcher at the Helmholtz Centre for Environmental Research (UFZ) in Leipzig, Germany.

    Topic: Active transport in the context of ADME in the zebrafish embryo

  • Dr. Ian D. Kerr

    Professor, School of Life Sciences, University of Nottingham, Nottingham, United Kingdom.

    Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2

  • Dr. Anna Seelig

    Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John’s University, Queens, NY, USA.

    Topic: A new model for allocrite transport by P-glycoprotein

  • Dr. Xiaozhuo Chen

    Associate Investigator, Edison Biotechnology Institute Associate Professor, Microbiology Heritage College of Osteopathic Medicine, Biomedical Sciences, Ohio University. USA.

    Topic: Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells

  • Dr. Antonio Tito Fojo

    The Senior Investigator and Program Director, Medical Oncology Fellowship Program, National Cancer Institute, National Institutes of Health in Bethesda.

    Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance

    Professor of Medicine at Columbia University Irving Medical Center

Programme

      Time (GMT+2)
      Speakers
      Topics
      2:00-2:10 PM
      Thomas Litman
      Welcome - The ABC of MDR
      2:10-2:20 PM
      Michael M. Gottesman
      Development of a Zebrafish model to study the role of ABC transporters at the Blood-Brain Barrier
      2:20-2:25 PM
      All Experts
      Discussion with  the speaker (Q&A )
      2:25-2:35 PM
      Xiaozhuo Chen
      Extracellular ATP-induced and ABC transporter-mediated drug resistance in human cancer cells
      2:35-2:40 PM 
      All Experts
      Discussion with  the speaker (Q&A )
      2:40-2:50 PM 
      Anna Seelig
      A new model for allocrite transport by P-glycoprotein
      2:50-2:55 PM 
      All Experts
      Discussion with  the speaker (Q&A )
      2:55-3:05 PM 
      Till Luckenbach
      Active transport in the context of ADME in the zebrafish embryo
      3:05-3:10 PM
      All Experts
      Discussion with  the speaker (Q&A )
      3:10-3:20 PM
      Ian D. Kerr
      Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
      3:20-3:25 PM 
      All Experts
      Discussion with  the speaker (Q&A )
      3:25-3:35 PM 
      Antonio Tito Fojo
      Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
      3:35-3:40 PM 
      All Experts
      Discussion with  the speaker (Q&A )
      3:40-3:50 PM
      All Experts
      Free Discussion 
      3:50-3:55 PM 
      Assistant  Editor
      Journal Introduction 
      3:55-4:00 PM 
      Thomas Litman
      Concluding Comments

Moments

Presentation

  • Prof. Thomas Litman
    Topic: The ABC of MDR
  • Dr. Till Luckenbach
    Topic: Active transport in the context of ADME in the zebrafish embryo
  • Dr. Ian D. Kerr
    Topic: Use of a TR-FRET assay to explore inhibitor and substrate binding in ABCG2
  • Dr. Anna Seelig
    Topic: A new model for allocrite transport by P-glycoprotein
  • Dr. Antonio Tito Fojo
    Topic: Widely deployed genomic analyses lack meaningful information on mechanisms of drug resistance
© 2016-2022 OAE Publishing Inc., except certain content provided by third parties